← Leaderboards
Irene T Weber
Thomas Jefferson University
$5,190,224
Attributed
$6,603,015
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $410.1K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,603,015 · 5
By mechanism
R01$3,320,364 · 1
U01$2,825,582 · 2
P01$258,493 · 1
R03$198,576 · 1
Top collaborators
- Robert Wilson Harrison11 shared
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantDrug ResistanceAntiviral AgentsProtease InhibitorStructureHiv ProteaseViralPharmaceutical PreparationsResistanceChemical SynthesisMutationVariantAids TherapyBinding SitesMolecularPeptide HydrolasesResistance MechanismBaseDesignInhibitor/AntagonistSurgical FlapsAids/Hiv ProblemEvolutionResistance Mutation
Grant awards (32)
Inhibition of Resistant Variants of HIV Protease$345,420
U01 · FY2020 · AI · contact PI
Inhibition of Resistant Variants of HIV Protease$345,420
U01 · FY2019 · AI · contact PI
Inhibition of Resistant Variants of HIV Protease$345,420
U01 · FY2018 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$11,400
U01 · FY2018 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$345,420
U01 · FY2017 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$327,820
U01 · FY2016 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$366,803
U01 · FY2015 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$327,820
U01 · FY2014 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$43,256
U01 · FY2014 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$38,983
U01 · FY2014 · GM · contact PI
Inhibition of Resistant Variants of HIV Protease$327,820
U01 · FY2013 · GM · contact PI
Activity of Resistant Variants of HIV Protease$318,656
R01 · FY2012 · GM · contact PI
Activity of Resistant Variants of HIV Protease$318,656
R01 · FY2011 · GM · contact PI
Activity of Resistant Variants of HIV Protease$321,874
R01 · FY2010 · GM · contact PI
Activity of Resistant Variants of HIV Protease$325,125
R01 · FY2009 · GM · contact PI
Activity of Resistant Variants of HIV Protease$295,236
R01 · FY2007 · GM · contact PI
Activity of Resistant Variants of HIV Protease$304,053
R01 · FY2006 · GM · contact PI
Activity of Resistant Variants of HIV Protease$311,370
R01 · FY2005 · GM
Activity of Resistant Variants of HIV Protease$311,370
R01 · FY2004 · GM
Specificity Studies of HIV and HTLV Proteases$40,320
R03 · FY2004 · TW
Specificity Studies of HIV and HTLV Proteases$40,320
R03 · FY2003 · TW
ACTIVITY OF RESISTANT VARIANTS OF HIV PROTEASE$288,618
R01 · FY2002 · GM
Specificity Studies of HIV and HTLV Proteases$38,500
R03 · FY2002 · TW
Structural Analysis of TCL-1 and MTCP-1 Proteins$0
P01 · FY2002 · CA
ACTIVITY OF RESISTANT VARIANTS OF HIV PROTEASE$238,495
R01 · FY2001 · GM
ACTIVITY OF RESISTANT VARIANTS OF HIV PROTEASE$48,416
R01 · FY2001 · GM
SPECIFICITY STUDIES OF HIV AND HTLV PROTEASES$39,718
R03 · FY2001 · TW
Structural Analysis of TCL-1 and MTCP-1 Proteins$0
P01 · FY2001 · CA
Structural Analysis of TCL-1 and MTCP-1 Proteins$258,493
P01 · FY2000 · CA
ACTIVITY OF RESISTANT VARIANTS OF HIV PROTEASE$238,495
R01 · FY2000 · GM
SPECIFICITY STUDIES OF HIV AND HTLV PROTEASES$32,224
R03 · FY2000 · TW
SPECIFICITY STUDIES OF HIV AND HTLV PROTEASES$7,494
R03 · FY2000 · TW